Baidu
map

JAMA Netw Open:梦游者患帕金森病风险比常人高出4倍!

2021-04-21 MedSci原创 MedSci原创

自1990年以来,帕金森病(PD)是全球患病率,致残率和死亡率增长最快的神经系统疾病。

1990年以来,帕金森病(PD)是全球患病率,致残率和死亡率增长最快的神经系统疾病。PD患者常出现运动障碍,但也会观察到一些非运动性特征,这可能与进行性神经变性相关。识别非运动症状对于理解PD疾病的病理学和临床意义至关重要。

pixabay

快速眼动睡眠行为障碍(RBD)是PD的研究最广泛的非运动功能之一。先前有研究显示,除了RBD之外,特别是梦游,与PD的严重程度相关。然而,在基于人群的研究中,仍不清楚梦游与PD的患病之间的关系。

近日,发表在JAMA Netw Open杂志的一项研究显示,梦游或患有RBD的男性患PD风险可能更高。与没有梦游或者RBD的男性相比,梦游者或患有RBD的男性患PD风险高出4倍以上。

在这项研究中,研究人员收集了来自20121月至20186月美国男性健康专业人员的队列研究25694名男性,进而评估梦游和RBD对痴呆症发病率的影响。

结果显示,在这些男性中,223名(0.9%)为梦游者,RBD者为2720名(10.6%),而PD患者为257名(1.0%)。在调整了可能的混杂因素后,包括年龄,吸烟,咖啡因摄入量,慢性病状态和其他睡眠障碍,研究人员发现梦游的男性患PD风险高出4倍,RBD的风险增加了6倍,而梦游合并RBD风险都增加了8倍。

睡眠行为障碍对帕金森病的影响

研究人员表示,PD中的睡眠中断很常见。先前的一项调查报告表示,有64%的PD患者有睡眠问题。睡眠中断是多因素的,包括PD的非运动症状,夜间震颤和昼夜节律紊乱等有关。睡眠碎片可能是导致PD患者梦游和RBD发生频率较高的主要因素。尽管我们未评估睡眠碎片带来的影响,但我们观察到较高比例的梦游和RBD患者白天过度嗜睡,并且睡眠时间缩短(<6小时)或延长(> 8小时)。

原始出处

Xinyuan Zhang, BS1; Samantha A. Molsberry, PhD2Milena Pavlova, MD3; et al.Association of Sleepwalking and REM Sleep Behavior Disorder With Parkinson Disease in Men.JAMA Netw Open. 2021;4(4):e215713. doi:10.1001/jamanetworkopen.2021.5713

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1734352, encodeId=6da71e3435213, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Fri Jan 07 00:41:57 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728917, encodeId=aa1b1e28917dd, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 23 19:41:57 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078467, encodeId=9c0720e8467c2, content=<a href='/topic/show?id=1842100886df' target=_blank style='color:#2F92EE;'>#风险比#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100886, encryptionId=1842100886df, topicName=风险比)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Wed Mar 09 16:41:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036584, encodeId=4f9a103658491, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Apr 21 23:41:57 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2022-01-07 canlab
  2. [GetPortalCommentsPageByObjectIdResponse(id=1734352, encodeId=6da71e3435213, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Fri Jan 07 00:41:57 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728917, encodeId=aa1b1e28917dd, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 23 19:41:57 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078467, encodeId=9c0720e8467c2, content=<a href='/topic/show?id=1842100886df' target=_blank style='color:#2F92EE;'>#风险比#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100886, encryptionId=1842100886df, topicName=风险比)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Wed Mar 09 16:41:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036584, encodeId=4f9a103658491, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Apr 21 23:41:57 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2021-09-23 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1734352, encodeId=6da71e3435213, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Fri Jan 07 00:41:57 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728917, encodeId=aa1b1e28917dd, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 23 19:41:57 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078467, encodeId=9c0720e8467c2, content=<a href='/topic/show?id=1842100886df' target=_blank style='color:#2F92EE;'>#风险比#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100886, encryptionId=1842100886df, topicName=风险比)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Wed Mar 09 16:41:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036584, encodeId=4f9a103658491, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Apr 21 23:41:57 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1734352, encodeId=6da71e3435213, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Fri Jan 07 00:41:57 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728917, encodeId=aa1b1e28917dd, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 23 19:41:57 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078467, encodeId=9c0720e8467c2, content=<a href='/topic/show?id=1842100886df' target=_blank style='color:#2F92EE;'>#风险比#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100886, encryptionId=1842100886df, topicName=风险比)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=947269, createdName=lvygwyt2781, createdTime=Wed Mar 09 16:41:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036584, encodeId=4f9a103658491, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Apr 21 23:41:57 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2021-04-21 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

相关资讯

Neurology:中国原创研究-帕金森的运动表型和大脑皮层褶皱化息息相关

帕金森的运动表型和大脑皮层褶皱化息息相关

世界帕金森病日|陈生弟教授谈帕金森病的诊疗现状和新近进展

每年的4月11日是世界帕金森病日。帕金森病是一种常见的中老年神经系统退行性疾病,我国65岁以上人群帕金森病的患病率为1700/10万1,与西方国家相似。由于我国人口基数大,因此,帕金森病患者群体庞大。

Ann Neurol:纳比龙可有效且安全的治疗伴非运动症状的帕金森病患者

帕金森病(PD)的非运动症状(NMS)包括自主神经系统功能障碍、嗅觉丧失、情绪和认知障碍,以及睡眠问题,如失眠、白天嗜睡或快速眼动(REM)睡眠行为障碍。NMS是决定PD患者生活质量、进行性残疾和依赖

J Neuroeng Rehabil:个性化定制的互动视频游戏训练可以改善轻中度帕金森病老年患者运动能力

帕金森病(Parkinson's disease,PD)是影响老年人的第二大常见神经退行性疾病。 运动项目有利于PD患者,在一定程度上改善体力和功能、与健康相关的生活质量、平衡和步态速度。然而,大多数

Neurology:干扰素信号抑制,不会干扰帕金森病风险或发病年龄

干扰素信号抑制,不会干扰帕金森病风险或发病年龄

Signal Transduct Target Ther:口服小檗碱改善帕金森

BBR是肠球菌中TH的激动剂,并可导致肠道中左旋多巴的产生。口服BBR可通过肠道细菌增加血/粪中的左旋多巴。因此,BBR可能通过类似维生素的作用上调肠道微生物区系中左旋多巴的生物合成来改善大脑功能。

Baidu
map
Baidu
map
Baidu
map